Xuan Xu

ORCID: 0000-0003-4908-8501 · 3 papers in corpus
observational 2026
BMC neurology ·doi:10.1186/s12883-026-04859-9

OBJECTIVE: To evaluate rimegepant’s effectiveness and safety in the short-term prevention of pure menstrual migraine. BACKGROUND: Rimegepant’s effectiveness and safety in both acute and preventive treatment of migraine have been demonstrate…

review 2025
Theranostics ·doi:10.7150/thno.121766

Autoimmune diseases are driven by a breach of self-tolerance, leading to chronic inflammation and organ damage. While the Th1 and Th17 paradigms have long dominated our understanding of T-cell-mediated pathology, a distinct subset of CD4+ T…

lab-animal 2024
Regenerative therapy ·doi:10.1016/j.reth.2024.03.030

INTRODUCTION: Cell transplantation is an emerging and effective therapeutic approach for enhancing uterine adhesions caused by endometrial damage. Currently, human umbilical cord blood mononuclear cells (HUCBMCs) have been extensively for t…